Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure

Keyphrases

• Activity Rate 11%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 22%
• Antiadrenergic 11%
• Arterial Baroreflex 100%
• Baroreflex 33%
• Baroreflex Control 100%
• Beneficial Effects 11%
• Bolus Administration 11%
• Cardiopulmonary Baroreflex 100%
• Central Venous Pressure 11%
• Congestive Heart Failure 22%
• Control Subjects 44%
• Enalaprilat 100%
• Head down 11%
• Heart Failure 33%
• Heart Rate 22%
• Lower Body Negative Pressure 11%
• Microneurography 11%
• Muscle Sympathetic Nerve Activity 11%
• Patients with Heart Failure 100%
• Phenylephrine 11%
• Reflex Control 11%
• Sodium Nitroprusside 11%
• Sympathetic Activity 22%
• Sympathetic Nerve Activity 100%
• Sympathetic Outflow 22%
• Systolic Blood Pressure 11%

Neuroscience

• ACE Inhibitor 18%
• Baroreflex 100%
• Enalaprilat 100%
• Microneurography 9%
• Nerve Conduction 100%
• Phenylephrine 9%
• Sodium Nitroprusside 9%
• Sympathetic Nerve 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Adrenergic Receptor Blocking Agent 11%
• Congestive Heart Failure 100%
• Dipeptidyl Carboxypeptidase Inhibitor 22%
• Enalaprilat 100%
• Nitroprusside Sodium 11%
• Phenylephrine 11%